Funding Details
- Date Award
- May 13, 2024
- Vertical
- Medtech
- Funding URL
- View Funding Page
Company Info
- Founders
- Un Kwon-Casado, Michael Lin
- Company Description
- Dahlia Biosciences is providing the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications. Our vision is to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.
- Market
- Human Health
- Location
-
United States
Links